« Back
Home /
Rabbit Anti-Human VEGFR2/KDR Affinity Purified pAb

Rabbit Anti-Human VEGFR2/KDR Affinity Purified pAb

Manufacturer	Cell Sciences
Category	Oncology Neuroscience Neural Lineage Markers Molecular Targets for Neuroscience Neural Signaling Neural Adhesion Molecules Antibodies By Cell Type Blastoma Carcinoma Glioma Hematology Leukemia Lymphoma Myeloma Melanoma Sarcoma Cell Biology Cell Movement Cell Adhesion Cell Culture Cytokines Adenocarcinoma Western Blot ELISA Primary Antibodies Astrocytoma By Organ Bladder Cancer Colorectal Cancer Thyroid Cancer Calcium Binding Protein Markers Interneuron Markers
Type	Antibody Polyclonal
Specific against	Human
Applications	WB, ELISA
Amount	50 ug
Host	Rabbit
Item no.	CS-CPV114
Targets	VEGFA, NTRK1, FGFR4, KDR
eClass 6.1	32160702
eClass 9.0	32160702
Available
Description	Rabbit Anti-human VEGFR2/KDR polyclonal antibody
Formulation	Lyophilized from PBS, pH 7.4, without preservative
Immunogen	Recombinant human soluble KDR protein (D1-7)
Purification	Biospecific affinity chromatography
Reconstitution	Centrifuge vial prior to opening . Add sterile distilled water to the vial to fully solubilize the antibody to a concentration of 1.0 mg/ml.
Storage and Stability	Store lyophilized antibody below 0C. Reconstituted antibody is stable for at least six weeks at 2-4C or stored in working aliquots at -20C for more than six months. Avoid repeated freeze-thaw cycles .
Specificity	Recognizes native and recombinant human VEGFR2

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

CS-CPV114.pdf

CS-CPV114-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 50 ug

available

Delivery expected until 5/30/2024